Showing 1 - 10 of 7,756
Equity in health has to be distinguished from equity in access to health care, or equity in the distribution of health care resources. We take as a working definition of health for our purposes the number of quality adjusted life years that a person may expect to enjoy over his or her lifetime....
Persistent link: https://www.econbiz.de/10014024170
The for-profit hospital is in the minority numerically in all developed countries. Although the for-profits' market share has been quite stable for decades, for-profit chains have grown in share and influence in the United States. By contrast, for-profit chains have made few inroads in other...
Persistent link: https://www.econbiz.de/10014024184
As in most industries, in health care, information is a competitive asset, and we expect that health care providers may have incentive to protect their information from competitors. This study aims to understand how this incentive to protect information may be a barrier to the development of a...
Persistent link: https://www.econbiz.de/10014036716
the literature. The second section evaluates the different drivers of the bank capital regulation …
Persistent link: https://www.econbiz.de/10013112529
Competing hospitals may not only use quality of service to attract patients but also their specialization profile. Applying a Hotelling-duopoly and interpreting respectively quality and specialization as vertical and horizontal differentiation, we analyze the optimal allocation in both...
Persistent link: https://www.econbiz.de/10011506836
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by …
Persistent link: https://www.econbiz.de/10010223101
Persistent link: https://www.econbiz.de/10014514558
manufacturer) on pharmaceutical regulation in a North-South framework with a firm's endogenous decision to export to the South … via reimbursement limits. Parallel trade may relax regulation in the source country of parallel imports (South) and … intensify regulation in the destination country (North): In the source country, parallel trade may relax regulation both under a …
Persistent link: https://www.econbiz.de/10011986314
This paper studies the effect of two regulatory instruments - a price cap and a reference price system - a mandatory substitution rule, and the combination of both on generic competition in a Salop-type model with an off-patent brand-name drug and n differentiated generic versions. The price cap...
Persistent link: https://www.econbiz.de/10010510801
This paper studies interaction of pharmaceutical regulation and parallel trade in a North-South framework. An … South being larger if both countries regulate as compared to only the South limiting reimbursement. Stricter regulation, i …
Persistent link: https://www.econbiz.de/10011290061